Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2730]

Empowering cancer care in Africa

Prof Cesaltina Ferreira Lorenzoni - Mozambican Ministry of Health, Maputo...

Empowering cancer care in Africa ( Prof Cesaltina Ferreira Lorenzoni - Mozambican Ministry of Health, Maputo, Mozambique and AORTIC President )

Do all hormone sensitive prostate cancers need triplet therapy?

Dr Deepak Dabkara - Tata Medical Center, Kolkata, India

Do all hormone sensitive prostate cancers need triplet therapy? ( Dr Deepak Dabkara - Tata Medical Center, Kolkata, India )

ESMO 2025: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada

ESMO 2025: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )

ctDNA-guided adjuvant atezolizumab improves OS in MIBC

Prof Thomas Powles - Barts Cancer Institute, London, UK

ctDNA-guided adjuvant atezolizumab improves OS in MIBC ( Prof Thomas Powles - Barts Cancer Institute, London, UK )

ctDNA-guided adjuvant chemo de-escalation reduces toxicity with comparable...

Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia

ctDNA-guided adjuvant chemo de-escalation reduces toxicity with comparable outcomes in stage III colon cancer ( Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia )

177Lu-PSMA-617 with androgen deprivation therapy plus ARPI improves PFS for...

Dr Scott Tagawa - Weill Cornell Medicine, New York, USA

177Lu-PSMA-617 with androgen deprivation therapy plus ARPI improves PFS for mHSPC ( Dr Scott Tagawa - Weill Cornell Medicine, New York, USA )

MCED blood test demonstrates high specificity, strong predictive value, and...

Dr Nima Nabavizadeh - Oregon Health & Science University, Portland, USA

MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection ( Dr Nima Nabavizadeh - Oregon Health & Science University, Portland, USA )

Circulating tumour DNA a useful marker in CRC treatment efficacy, but only...

Dr Emerik Österlund - MD Anderson Cancer Center, Houston, USA

Circulating tumour DNA a useful marker in CRC treatment efficacy, but only alongside others ( Dr Emerik Österlund - MD Anderson Cancer Center, Houston, USA )

Enhancing breast cancer care through AI and collaboration

Dr Gabrielle Speijer, Dr Fernando Suarez and Dr Tolga Ozmen

Enhancing breast cancer care through AI and collaboration ( Dr Gabrielle Speijer, Dr Fernando Suarez and Dr Tolga Ozmen )

ctDNA testing improves detection of treatable metastases compared to standard...

Dr Arvind Dasari - MD Anderson Cancer Center, Houston, USA

ctDNA testing improves detection of treatable metastases compared to standard care in colorectal cancer ( Dr Arvind Dasari - MD Anderson Cancer Center, Houston, USA )

Tumour microenvironment and circulating biomarkers predict response to...

Dr David Braun - Yale School of Medicine, New Haven, USA

Tumour microenvironment and circulating biomarkers predict response to immunotherapy in advanced RCC ( Dr David Braun - Yale School of Medicine, New Haven, USA )

ctDNA-guided chemo escalation does not improve recurrence-free survival in...

Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia

ctDNA-guided chemo escalation does not improve recurrence-free survival in stage III colon cancer ( Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia )

More from ecancer